BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 33519465)

  • 1. Discovery and Preclinical Development of Orally Active Small Molecules that Exhibit Highly Selective Follicle Stimulating Hormone Receptor Agonism.
    Nataraja S; Yu H; Guner J; Palmer S
    Front Pharmacol; 2020; 11():602593. PubMed ID: 33519465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral follicle-stimulating hormone receptor agonist affects granulosa cells differently than recombinant human FSH.
    Guner JZ; Monsivais D; Yu H; Stossi F; Johnson HL; Gibbons WE; Matzuk MM; Palmer S
    Fertil Steril; 2023 Nov; 120(5):1061-1070. PubMed ID: 37532169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypo-glycosylated hFSH drives ovarian follicular development more efficiently than fully-glycosylated hFSH: enhanced transcription and PI3K and MAPK signaling.
    Hua G; George JW; Clark KL; Jonas KC; Johnson GP; Southekal S; Guda C; Hou X; Blum HR; Eudy J; Butnev VY; Brown AR; Katta S; May JV; Bousfield GR; Davis JS
    Hum Reprod; 2021 Jun; 36(7):1891-1906. PubMed ID: 34059912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gonadotropin-releasing hormone antagonist versus agonist administration in women undergoing controlled ovarian hyperstimulation: cycle performance and in vitro steroidogenesis of granulosa-lutein cells.
    Minaretzis D; Alper MM; Oskowitz SP; Lobel SM; Mortola JF; Pavlou SN
    Am J Obstet Gynecol; 1995 May; 172(5):1518-25. PubMed ID: 7755066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human follicle stimulating hormone (r-hFSH; Gonal-F) versus highly purified urinary FSH (Metrodin HP): results of a randomized comparative study in women undergoing assisted reproductive techniques.
    Bergh C; Howles CM; Borg K; Hamberger L; Josefsson B; Nilsson L; Wikland M
    Hum Reprod; 1997 Oct; 12(10):2133-9. PubMed ID: 9402268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and characterization of a novel long-acting recombinant follicle stimulating hormone agonist by fusing Fc to an FSH-β subunit.
    Zhang YL; Guo KP; Ji SY; Liu XM; Wang P; Wu J; Gao L; Jiang TQ; Xu T; Fan HY
    Hum Reprod; 2016 Jan; 31(1):169-82. PubMed ID: 26621853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind, randomized study to compare recombinant human follicle stimulating hormone (FSH; Gonal-F) with highly purified urinary FSH (Metrodin) HP) in women undergoing assisted reproductive techniques including intracytoplasmic sperm injection. The French Multicentre Trialists.
    Frydman R; Howles CM; Truong F
    Hum Reprod; 2000 Mar; 15(3):520-5. PubMed ID: 10686190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of a thiazolidinone derivative as an allosteric modulator of follicle stimulating hormone receptor: evidence for its ability to support follicular development and ovulation.
    Sriraman V; Denis D; de Matos D; Yu H; Palmer S; Nataraja S
    Biochem Pharmacol; 2014 May; 89(2):266-75. PubMed ID: 24630928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of follicle-stimulating hormone-induced preovulatory follicles in rats treated with a nonsteroidal negative allosteric modulator of follicle-stimulating hormone receptor.
    Dias JA; Campo B; Weaver BA; Watts J; Kluetzman K; Thomas RM; Bonnet B; Mutel V; Poli SM
    Biol Reprod; 2014 Jan; 90(1):19. PubMed ID: 24285717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian stimulation with human and recombinant gonadotropin - comparison of in vitro fertilization efficiency with use of time-lapse monitoring.
    Wdowiak A; Bojar I
    Reprod Health; 2015 Dec; 12():113. PubMed ID: 26667662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of substituted benzamides as follicle stimulating hormone receptor allosteric modulators.
    Yu HN; Richardson TE; Nataraja S; Fischer DJ; Sriraman V; Jiang X; Bharathi P; Foglesong RJ; Haxell TF; Heasley BH; Jenks M; Li J; Dugas MS; Collis R; Tian H; Palmer S; Goutopoulos A
    Bioorg Med Chem Lett; 2014 May; 24(9):2168-72. PubMed ID: 24685543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A bolus of recombinant human follicle stimulating hormone at midcycle induces periovulatory events following multiple follicular development in macaques.
    Zelinski-Wooten MB; Hutchison JS; Hess DL; Wolf DP; Stouffer RL
    Hum Reprod; 1998 Mar; 13(3):554-60. PubMed ID: 9572409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poor second ovarian stimulation in cynomolgus monkeys (Macaca fascicularis) is associated with the production of antibodies against human follicle-stimulating hormone.
    Seita Y; Iwatani C; Tsuchiya H; Nakamura S; Kimura F; Murakami T; Ema M
    J Reprod Dev; 2019 Jun; 65(3):267-273. PubMed ID: 30842351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical assessment of recombinant human follicle-stimulating hormone in stimulating ovarian follicular development before in vitro fertilization. Recombinant Human FSH Study Group.
    Fertil Steril; 1995 Jan; 63(1):77-86. PubMed ID: 7805928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poor ovarian response to gonadotropin stimulation is associated with low expression of follicle-stimulating hormone receptor in granulosa cells.
    Cai J; Lou HY; Dong MY; Lu XE; Zhu YM; Gao HJ; Huang HF
    Fertil Steril; 2007 Jun; 87(6):1350-6. PubMed ID: 17296182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian responses in women to recombinant follicle-stimulating hormone and luteinizing hormone (LH): a role for LH in the final stages of follicular maturation.
    Sullivan MW; Stewart-Akers A; Krasnow JS; Berga SL; Zeleznik AJ
    J Clin Endocrinol Metab; 1999 Jan; 84(1):228-32. PubMed ID: 9920089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fine-tuning the dose of recombinant human follicle-stimulating hormone alfa to individualize treatment in ovulation induction and ovarian stimulation cycles: a real-world database analysis.
    Martini AE; Beall S; Ball GD; Hayward B; D'Hooghe T; Mahony MC; Collares F; Catherino AB
    Front Endocrinol (Lausanne); 2023; 14():1195632. PubMed ID: 37727455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for abnormal granulosa cell responsiveness to follicle-stimulating hormone in women with polycystic ovary syndrome.
    Coffler MS; Patel K; Dahan MH; Malcom PJ; Kawashima T; Deutsch R; Chang RJ
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1742-7. PubMed ID: 12679467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, controlled, first-in-patient trial of choriogonadotropin beta added to follitropin delta in women undergoing ovarian stimulation in a long GnRH agonist protocol.
    Fernández Sánchez M; Višnová H; Larsson P; Yding Andersen C; Filicori M; Blockeel C; Pinborg A; Khalaf Y; Mannaerts B;
    Hum Reprod; 2022 May; 37(6):1161-1174. PubMed ID: 35451013
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.